1. Home
  2. MAMA vs NKTX Comparison

MAMA vs NKTX Comparison

Compare MAMA & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mama's Creations Inc.

MAMA

Mama's Creations Inc.

N/A

Current Price

$12.78

Market Cap

602.1M

ML Signal

N/A

Logo Nkarta Inc.

NKTX

Nkarta Inc.

N/A

Current Price

$2.57

Market Cap

198.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MAMA
NKTX
Founded
2010
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
602.1M
198.2M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
MAMA
NKTX
Price
$12.78
$2.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
7
Target Price
★ $22.29
$10.83
AVG Volume (30 Days)
★ 750.9K
582.0K
Earning Date
09-03-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 44.44
11.88
EPS
★ 0.10
N/A
Revenue
★ $95,420,129.00
N/A
Revenue This Year
$30.28
N/A
Revenue Next Year
$12.49
N/A
P/E Ratio
$129.00
★ N/A
Revenue Growth
★ 95.54
N/A
52 Week Low
$9.90
$1.70
52 Week High
$21.00
$3.72

Technical Indicators

Market Signals
Indicator
MAMA
NKTX
Relative Strength Index (RSI) 35.48 42.51
Support Level $12.89 $2.28
Resistance Level $14.97 $3.29
Average True Range (ATR) 0.65 0.17
MACD 0.01 -0.05
Stochastic Oscillator 12.90 10.00

Price Performance

Historical Comparison
MAMA
NKTX

About MAMA Mama's Creations Inc.

Mama's Creations Inc manufactures and markets fresh deli-prepared foods distributed through grocery, mass, club, and convenience stores across the United States. Its product portfolio includes refrigerated prepared foods such as meatballs, meatloaf, sausage products, and pasta and rice entrees. The products are principally sold to supermarkets, club chains, mass-market retailers, and food distributors. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: